Skip to Content

54 213 54 213 (Lithium 150 mg)

This pill with imprint "54 213 54 213" is White, Capsule-shape and has been identified as Lithium carbonate 150 mg. It is supplied by Roxane Laboratories, Inc..

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; cyclothymic disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213

Lithium carbonate

Imprint:
54 213 54 213
Strength:
150 mg
Color:
White
Size:
4.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roxane Laboratories, Inc.
Inactive Ingredients:
FD&C Red No. 40
gelatin
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferrosoferric oxide
povidone k30
shellac
Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Labelers / Repackagers:
NDC CodeLabeler / Repackager
00054-2526 Roxane Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide